Blair William & CO Dynavax Technologies Corp Call Options Transaction History

Blair William & CO

  • $33.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Nov 13, 2018
BUY
$11.85 - $16.0 $9,480 - $12,800
800 Added 15.38%
6,000 $74,000
Q2 2018

Aug 13, 2018
BUY
$15.15 - $20.75 $18,180 - $24,900
1,200 Added 30.0%
5,200 $79,000
Q1 2018

May 15, 2018
SELL
$14.65 - $19.9 $20,510 - $27,859
-1,400 Reduced 25.93%
4,000 $79,000
Q4 2017

Feb 14, 2018
BUY
$17.3 - $24.08 $93,420 - $130,031
5,400
5,400 $101,000

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.48B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email